Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cue Health Inc (NQ: HLTH )

0.5500 -0.0010 (-0.18%)
Streaming Delayed Price Updated: 9:46 AM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cue Health Inc

< Previous 1 2 3 4 Next >
Cue Health Becomes First Company to Receive FDA De Novo Authorization COVID-19 Home Use Test
Cue Health Inc (NASDAQ: HLTH) became the first company to receive De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for both home and  
Via Benzinga
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
From Cue Health
Via Business Wire
Expert Ratings for Cue Health
 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  Monday's session saw 41 companies set new 52-week lows. 
Via Benzinga
Recap: Cue Health Q1 Earnings
 
Via Benzinga
Earnings Preview: Cue Health
 
Via Benzinga
Cue Health Earnings Perspective: Return On Invested Capital
 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 69 stocks hit new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Cue Health's Earnings Outlook
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023
 
Via Benzinga
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
From Cue Health Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Cue Health Reports First Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
From Cue Health
Via Business Wire
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China. 
Via Benzinga
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home
From Cue Health
Via Business Wire
Cue Health to Announce First Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test
From Cue Health
Via Business Wire
Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results
From Cue Health Inc.
Via Business Wire
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
Cue Health’s New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
From Cue Health
Via Business Wire
Cue Health Collaborates with Pfizer to Provide People who Test Positive for COVID-19 with Actionable Health Information to Better Inform their Treatment Journey
From Cue Health
Via Business Wire
Cue Health to Announce Fourth Quarter and Full-Year 2022 Financial Results
From Cue Health Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Cue Health to Participate at Upcoming Investor Conferences
From Cue Health Inc.
Via Business Wire
Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit... 
Via Benzinga
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.